Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study-Reference-Cited by-同舟云学术

Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study

Published:2022-02 Issue:8 Volume:40 Page:1082-1089
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Li Lucy L.,Zheng Chunlei,La Jennifer,Do Nhan V.,Monach Paul A.,Strymish Judith M.,Fillmore Nathanael R.,Branch-Elliman Westyn

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference38 articles.

1. US Food and Drug Administration (FDA). COVID-19 Vaccines; 2021. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines.

2. Pradhan PM, Shen Z, Li C, Remucal MJ. Comparison of adverse events between COVID-19 and Flu vaccines. medRxiv 2021. 2021.09.22.21263711.

3. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine;Baden;N Engl J Med,2021

4. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N Engl J Med,2020

5. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19;Sadoff;N Engl J Med,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines;Experimental & Molecular Medicine;2023-07-10

2. Longitudinal Analysis of Humoral and Cellular Immune Response Following SARS-CoV-2 Vaccination Supports Utilizing Point-Of-Care Tests to Enhance COVID-19 Booster Uptake;2023-04-04

3. Risk and Benefit of mRNA COVID-19 Vaccines for the Omicron Variant by Age, Sex, and Presence of Comorbidity: A Quality-Adjusted Life Years Analysis;American Journal of Epidemiology;2023-03-14

4. Hospitalization Rates Following mRNA SARS-CoV-2 Booster Vaccination among Patients with and without Prior SARS-CoV-2 Infection: A Nationwide, Retrospective Cohort Study;2023-02-17

5. A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination;Vaccine;2023-01